Gene · 189
Papers3,768
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,768
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Developing advanced datadriven framework to predict the bearing capacity of piles on rock. | Sci Rep | 2025 | 40169682 | PubTator, text mining | PubMed |
| Oral and Poster Abstracts of the 13th ISNS European Regional Meeting. | Int J Neonatal Screen | 2025 | 40136636 | PubTator, text mining | PubMed |
| Assessment of Hammer Energy Measurement for the Standard Penetration Test (SPT) Using Pile Driving Analyzer and Kallpa Analyzer Devices in Peru. | Sensors (Basel) | 2025 | 40096284 | PubTator, text mining | PubMed |
| Population-based, first-tier genomic newborn screening in the maternity ward. | Nat Med | 2025 | 39875687 | PubTator, text mining | PubMed |
| Variable treatment response to lumasiran in pediatric patients with primary hyperoxaluria type 1. | Pediatr Nephrol | 2025 | 39869204 | PubTator, text mining | PubMed |
| Sphingoid Base Diversity. | Atherosclerosis | 2025 | 39824719 | PubTator, text mining | PubMed |
| Effective Newborn Screening for Type 1 and 3 Primary Hyperoxaluria. | Kidney Int Rep | 2025 | 39810772 | PubTator, text mining | PubMed |
| Biallelic Variant in the AGXT Gene in a Family Segregating Primary Hyperoxaluria; Accurate Genetic Diagnosis and Carrier Detection. | Nephrology (Carlton) | 2025 | 39746862 | PubTator, text mining | PubMed |
| Effect of the allelic background on the phenotype of primary hyperoxaluria type I. | Curr Opin Nephrol Hypertens | 2025 | 39641329 | PubTator, text mining | PubMed |
| Genetic Etiology Investigation in Treatment-Resistant Nocturnal Enuresis Children: A descriptive study. | Urol J | 2025 | 39616448 | PubTator, text mining | PubMed |
| The lack of trade-off between conformational stability and binding affinity in a nanobody with therapeutic potential for a misfolding disease. | Int J Biol Macromol | 2025 | 39603302 | PubTator, text mining | PubMed |
| Thermodynamic versus kinetic basis for the high conformational stability of nanobodies for therapeutic applications. | FEBS Lett | 2025 | 39593207 | PubTator, text mining | PubMed |
| Human glyoxylate metabolism revisited: New insights pointing to multi-organ involvement with implications for siRNA-based therapies in primary hyperoxaluria. | J Inherit Metab Dis | 2025 | 39582099 | PubTator, text mining | PubMed |
| Altered sphingolipid biosynthetic flux and lipoprotein trafficking contribute to trans-fat-induced atherosclerosis. | Cell Metab | 2025 | 39547233 | PubTator, text mining | PubMed |
| Long Chain Base Profiling with Multiple Reaction Monitoring Mass Spectrometry. | Methods Mol Biol | 2025 | 39354311 | PubTator, text mining | PubMed |
| Navigating Complexity: Spiritual Care Discourses Among Swedish Palliative Care Professionals. | J Relig Health | 2025 | 39162774 | PubTator, text mining | PubMed |
| Unveiling atypical diagnoses: when whole-genome analysis performed for refractory infantile hypomagnesemia reveals primary hyperoxaluria. | Pediatr Nephrol | 2025 | 39088056 | PubTator, text mining | PubMed |
| A case of nephrocalcinosis in a 7-month-old with congenital hypothyroidism: Insights from targeted exome sequencing. | Pediatr Discov | 2024 | 40626246 | PubTator, text mining | PubMed |
| Atacama Large Aperture Submillimeter Telescope (AtLAST) science: Resolving the hot and ionized Universe through the Sunyaev-Zeldovich effect. | Open Res Eur | 2024 | 40162090 | PubTator, text mining | PubMed |
| Ms44-SPT: unique genetic technology simplifies and improves hybrid maize seed production in sub-Saharan Africa. | Sci Rep | 2024 | 39738785 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/189/papers?page=11